pbr28
Small moleculeexperimentalImaging agent
Clinical trial activity
17 trials · 20 clinical orgs · 0 marketing orgs
Phase 1
11
Phase 2
5
Phase 3
0
Phase 4
2
Earliest trial started Jan 26, 2006 (NCT00283920)
Timeline
Indications
Approved for
Studied for
- AIDS Dementia Complex · Phase 1/Phase 2
- Alcohol-Induced Disorders · Early Phase 1
- Alzheimer Disease · Phase 2
- Amyotrophic Lateral Sclerosis · Phase 1
- Anesthesia · Phase 4
- Atherosclerosis · Phase 1
- Blast Injuries · Phase 2
- Brain Injuries, Traumatic · Phase 1/Phase 2
- Cognition Disorders · Phase 4
- General Surgery · Phase 4
- Healthy Volunteers · Phase 1/Phase 2
- HIV · Phase 1/Phase 2
- HIV Infections · Phase 1/Phase 2
- Lewy Body Disease · Phase 2
- Multiple Sclerosis · Phase 4
- Neurocysticercosis · Phase 1
- Neurogenic Inflammation · Phase 4
- Parkinson Disease · Phase 2
- Psychiatry · Phase 1
Mechanism of action
- Translocator proteinBINDING AGENT
TSPO binding agent
Chemistry & pharmacology
- Imaging
- 11-carbon
Oral
No
Parenteral
No
Topical
No
Also known as
- 11c pbr28
- 11c pbr28
- 11c-pbr28
- 11c-pbr28
- 11c-pbr28
- (methyl-(11)c)n-acetyl-n-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine
- pbr28
- pbr28
- prb28
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07131475 | Phase 2 | Oct 14, 2025 | Harvard University, National Institutes of Health (NIH), Navy SEAL Foundation, Uniformed Services University of the Health Sciences, University of South Florida |
| NCT05586581 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2022 | National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Yale University |
| NCT04490096 | Phase 1 | Feb 25, 2021 | Biogen, University of Kansas, University of Miami, University of Pennsylvania |
| NCT04274998 | Early Phase 1 (Phase 1) | Mar 1, 2020 | University of Pennsylvania |
| NCT04230174 | Phase 4 | Feb 29, 2020 | Genentech, Harvard University |
| NCT03705715 | Phase 1 | May 1, 2017 | University of Texas at Houston |
| NCT02831283 | Phase 2 | Jun 1, 2016 | Columbia University, National Institute on Aging (NIA) |
| NCT02702102 | Phase 2 | Dec 1, 2015 | Columbia University, National Institute on Aging (NIA) |
| NCT02233868 | Early Phase 1 (Phase 1) | Sep 3, 2014 | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| NCT01881646 | Phase 4 | Jun 1, 2013 | Karolinska Institute, University of Copenhagen |
| NCT01547780 | Phase 1/Phase 2 (Phase 2) | Jan 20, 2012 | National Institute of Mental Health (NIMH), Suburban Hospital, Uniformed Services University of the Health Sciences |
| NCT00547976 | Phase 1 | Oct 1, 2007 | National Institute of Mental Health (NIMH) |
| NCT00526916 | Phase 1 | Sep 4, 2007 | National Institute of Mental Health (NIMH) |
| NCT00459693 | N/A | Apr 9, 2007 | National Institute of Mental Health (NIMH) |
| NCT00432900 | Phase 1 | Feb 5, 2007 | National Institute of Neurological Disorders and Stroke (NINDS) |
| NCT00407693 | Phase 1 | Nov 28, 2006 | National Institute of Mental Health (NIMH) |
| NCT00283920 | Phase 1 | Jan 26, 2006 | National Institute of Mental Health (NIMH) |
Showing 17 of 17 trials
Page 1 / 1
Organizations
Research & Development (20)
20 organizations
Page 1 / 1